Resources

PATH delivers statement at the 71st World Health Assembly on addressing the global shortage of, and access to, medicines and vaccines.

PATH and partners pen letter to US government officials opposing proposed rescission of unspent 2015 Ebola supplemental funds from the International Disaster Assistance account. Read the statement

Antimicrobial resistance (AMR), whereby a bacteria, virus, parasite or fungi becomes resistant to the antimicrobial drug that treats it, is recognized as one of greatest global threats to human and animal health and safety. In Vietnam, PATH is tackling this ever-evolving threat from all sides, through a range of cross-sectoral approaches.

Since 2012, PATH has been at the forefront of a movement to integrate nurturing care for early childhood development services into existing health systems—an important platform to reach children under three in low-resource settings.

PATH and Johnson & Johnson Vietnam are collaborating on Breath for Life, a new project to reduce childhood tuberculosis (TB) illness and death in Vietnam. Breath for life will strengthen the detection, treatment, and management of TB in children in NgheAn, a province highly burdened by TB, in partnership with the Vietnam National Tuberculosis Programme.